Freezing gallstone disease in its tracks

The first minimally invasive gallbladder ablation solution that gives patients the benefits of surgery, without the risk.


Innovative Team of Industry, Clinical and Business Experts

Born out of the Texas Medical Center (TMC) Biodesign fellowship, Ictero is a team of passionate engineers, scientists, clinicians, and entrepreneurs dedicated to developing innovative medical technology that addresses today’s most pressing clinical needs.

Ictero methodically developed The CholeSafe System to be a commercially viable, definitive, and safe treatment for gallstone disease.

Matthew Nojoomi, MSE

CEO, Co-Founder

David Waters, MD

COO, Co-Founder

Kovi Bessoff, MD, PhD

Clinical Research Lead,

Raymond Kirk, MD, FACR


Supporting Partners

Johnson & Johnson Innovation JLABS logo

Contact Us